OCT technology seems to have a promising future, but not just in the clinic or hospital. Due to dropping costs, OCT technology quite possibly has a future for home care. As SPIE Photonics West begins, we caught up with Adam Wax, President of Lumedica to get his take on the future of this tech.
Q&A with Adam Wax, President of Lumedica
Dr. Adam Wax is President and Chief Scientist of Lumedica based out of Durham, NC. Lumedica creates affordable medical OCT instruments. Leveraging off-the-shelf and custom imaging components, Lumedica reduces the cost of diagnostic devices, increases durability and makes them easier to distribute.
In a clinical setting, do you see OCT imaging replacing the need for MRI, CT, scans or other technology?
As you make OCT imaging more affordable, do you see a future in the consumer market? If so, could patient wearables self detect diseases without physician intervention?
What other practical uses do you see for OEMs integrating your OCT technology?
Attend Dr. Adam Wax’s panel discussion at SPIE Photonics West.
More SPIE Photonics West Interviews
Check out our other interview with Ryan Shelton, Ph.D, CEO of PhotoniCare >
Come see Accumold at Booth #2427
Come visit us at SPIE Photonics West. Accumold is a world leader in optics and medical micro molding and we love to highlight leading minds in the field.
Do you have a mico molding question that can’t wait?